Salomon Azoulay sold $2.7M of MBX Biosciences (MBX)

Executed May 8, disclosed May 11, 3 days later.

Value, as filed

$2.7M

70,003 sh across 2 lots

Executed

May 8

the trade date, as filed

Disclosed

May 11

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SA Salomon Azoulay Chief Medical Officer profile →

Salomon Azoulay (Chief Medical Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in MBX. The largest single filing was $2.7M of MBX (70,003 sh across 2 lots, as filed), executed May 8.

The name

MBX MBX MBX · 8 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→